Dutasteride Capsule, Liquid Filled
Product Images NDC 25000-011

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 25000-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marksans Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dutasteride-30ct (Dutasteride 30ct Bottle Label)

Dutasteride-30ct (Dutasteride 30ct Bottle Label)
Label for Dutasteride Capsules 0.5 mg liquid-filled capsules by Marksans Pharma Limited. The label indicates a 30-capsule container with instructions and warnings. It includes the NDC 25000-011-03, a barcode, storage instructions, manufacturer and distributor information.*
FDA Label Image

Dutasteride-90ct (Dutasteride 90ct Bottle Label)

Dutasteride-90ct (Dutasteride 90ct Bottle Label)
Label for Dutasteride Capsules 0.5 mg, liquid-filled oral capsules in a 90 capsule package. The label includes dosage and storage instructions, warnings, and manufacturing information. The product is labeled by Marksans Pharma Limited, with distribution by Time-Cap Labs, Inc. A barcode and NDC 25000-011-07 are also visible.*
FDA Label Image

Dutasteride-pic2 (Dutasteride Pic2)

Dutasteride-pic2 (Dutasteride Pic2)
A cumulative event curve chart comparing the placebo group and dutasteride group over 24 months of treatment. The y-axis indicates the percent of patients, while the x-axis shows months of treatment. The chart includes data points for the number of events and patients at risk for both groups at various time intervals.*
FDA Label Image

Dutasteride-pic3 (Dutasteride Pic3)

Dutasteride-pic3 (Dutasteride Pic3)
A cumulative event curve chart comparing placebo and Dutasteride groups over 24 months of treatment, showing the number of patients at risk and cumulative number of events at specified intervals.*
FDA Label Image

Dutasteride-pic4 (Dutasteride Pic4)

Dutasteride-pic4 (Dutasteride Pic4)
A bar chart showing mean percent change from baseline over months of treatment (0, 1, 3, 6, 12, 24) comparing placebo and dutasteride groups. The vertical axis represents mean percent change, and the horizontal axis represents months of treatment. Sample sizes for each group and time point are listed below the chart.*
FDA Label Image

Dutasteride-pic6 (Dutasteride Pic6)

Dutasteride-pic6 (Dutasteride Pic6)
A line graph depicting the mean change from baseline in PSA levels over 48 months of treatment. The x-axis represents months of treatment (0 to 48), and the y-axis shows mean change from baseline in PSA values. Three lines compare Dutasteride plus tamsulosin, Dutasteride 0.5 mg, and tamsulosin 0.4 mg groups.*
FDA Label Image

Dutasteride-pic7 (Dutasteride Pic7)

Dutasteride-pic7 (Dutasteride Pic7)
A line graph depicting mean change from baseline in mL/sec over 24 months of treatment for three groups: Dutasteride plus tamsulosin, Dutasteride 0.5 mg, and Tamsulosin 0.4 mg. The x-axis indicates months of treatment (0, 6, 12, 18, 24) and the y-axis shows mean change in flow rate, with data points plotted for each group over time.*
FDA Label Image

Dutasteride-str (Dutasteride Structure)

Dutasteride-str (Dutasteride Structure)
Chemical structure of Dutasteride, showing its steroid backbone with associated functional groups including trifluoromethyl-substituted aromatic ring and amide linkage.*
FDA Label Image

Dutasteride-pic5 (Dutasterie Pic5)

Dutasteride-pic5 (Dutasterie Pic5)
A line graph showing mean change from baseline over 24 months of treatment, comparing Dutasteride 0.5 mg and placebo. The y-axis represents mean change in mL/sec, and the x-axis shows months of treatment from 0 to 24. Dutasteride shows a gradual increase, while placebo remains near baseline.*
FDA Label Image

Dutasteride-pic1 (Dutatseride Pic1)

Dutasteride-pic1 (Dutatseride Pic1)
A line chart showing mean change from baseline in AUASI over 24 months of treatment comparing placebo and Dutasteride. The y-axis represents mean change from baseline in AUASI, and the x-axis shows months of treatment from 0 to 24. Dutasteride shows a greater reduction over time compared to placebo, with data points labeled by sample sizes for each group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.